Vimarsana
Biggest News Aggregation in the World

Page 43 - Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immune Today - Breaking & Trending Today

Interstitial macrophages trigger severe COVID in the lung - Vimarsana News

Interstitial macrophages trigger severe COVID in the lung

SARS-CoV-2 could proliferate in the lungs causing severe COVID-19 through a special type of immune cell. A group of scientists from Stanford University observed how this coronavirus infected interstitial macrophages through a CD209 receptor, triggering the inflammatory response observed in hospitalized patients.

Neuropeptide released by pain neurons promotes wound healing by interacting with immune system - Vimarsana News

Neuropeptide released by pain neurons promotes wound healing by interacting with immune system

Wound healing is a highly specialized dynamic process for the repair of damaged/injured tissues through an intricate mechanism. Any failure in the normal wound healing process results in abnormal scar formation, and a chronic state which is more susceptible to infections. Researchers from Monash University in Australia and Osaka University in Japan have demonstrated that the removal of a specific subtype of sensory neurons containing the Nav1.8+ ion channel significantly impairs skin wound repair and muscle regeneration following injury.

Biosimilars coming into their own in China, despite concerns - Vimarsana News

Biosimilars coming into their own in China, despite concerns

The timing is ripe for a robust biosimilar market in China, given the rapid increase of novel biologics approved to treat cancer and inflammatory diseases in the country over the past decade and the looming patent cliffs for several established biologics. As of December, the NMPA had approved more than 20 biosimilars that were developed in China. Most of those referenced just two biologics – Roche AG’s cancer drug Avastin (bevacizumab) and Abbvie Inc.’s immunology drug Humira (adalimumab). In 2022, the oncology and immunology biosimilar market in China garnered sales of about $2 billion,...

Moderna receives a $750M infusion from Blackstone - Vimarsana News

Moderna receives a $750M infusion from Blackstone

Blackstone Life Sciences made an investment of up to $750 million in Moderna Inc.’s influenza program created with its mRNA technology. The new funding is designed to help propel the program forward and may help bolster a stock that has struggled in the past 12 months.

Australian researchers discover gene mutation that causes psoriasis - Vimarsana News

Australian researchers discover gene mutation that causes psoriasis

Scientists from the Australian National University have discovered the gene mutation responsible for causing psoriasis, and the findings could lead to improved diagnosis and treatment for patients with psoriasis and psoriatic arthritis, a chronic inflammatory skin disease. “We were able to identify the gene that could be important in enabling this progression from a skin-only condition to a skin-and-joint condition,” lead study author Chelisa Cardinez told BioWorld.